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Buzzing of nanotechnology in each and every aspect of
science and technology has been booming at a tremendous
rate now a day. Started its journey from inorganic chemistry,
this ﬁeld has now even reached to aeronautical research,
and a special attention has been drawn in the medical and
allied braches for exploitation of the nanotech for attending
the limitations of the current scenario. Carrying foreword
the success of nanotechnology in ﬁeld of physical, chemical,
and medical sciences, it has now started revolutionizing the
drug delivery sciences. The speciﬁc advantages include su-
perior pharmacodynamics, pharmacokinetics, reduced tox-
icity, and targeting capability. Vehicle in the delivery sci-
ences being critical quality attribute needs special atten-
tion for tailor made design to rationalize the formulation
development; which can be successfully achieved via nan-
otechnology. Additionally, unique size-dependent properties
of nanosystems/nanodevices oﬀers excellent opportunities
for the development of novel “point-of-care” devices and
therapeutic tools. Drugs incorporated in the nanocarriers,
either physically entrapped or chemically tethered, have the
potential to target physiological disorder zone sparing nor-
mal cells from collateral consequences.
Targeting several molecular mechanisms, for either treat-
ment or prevention of diﬃcult-to-treat diseases, for the
design of the various nanotechnology-based drug delivery
systems is one of prime focuses of the formulation scientist
at the present juncture. Gene therapies and gene-based drug
delivery using nanocarriers are booming especially in case
of neoplastic extravasations. Various tumor suppressor genes
are identiﬁed, isolated and successfully formulated for treat-
ment of cancer. A remarkable number of such systems have
already made their pave and are under clinical trials, being
expected very soon at the end user level. Besides treating
these diseases, nanotechnology also oﬀers its contributions
in development of preventive measures such as vaccines.
Various nanotechnological adjuvants have been evaluated
for their capabilities to deliver vaccine subunits without
compromising the immunogenicity for successful design
and development of vaccine delivery systems. Furthermore,
regeneration ability of the visceral organs such as liver has
also been evaluated using nanocarriers, and the postulations
are on their way stating the enhanced cytoactivity of the
transplanted cells when cultured in nanocarriers.
The pharmacokinetic proﬁle, especially transportation
capabilities, of the drug substances have been greatly mod-
iﬁed by incorporation in nanodrug delivery system. These
include enhanced accommodation for targeting moieties
such as chaperones and alteration in release rates comprising
of controlled release and site-speciﬁc delivery by use of
molecular engineering techniques. Additionally, encapsu-
lation of the drug substances in various polymeric and
inorganic composites has also been evaluated for their ratio-
nalizing the drug delivery systems. Such encapsulations are
generally made for protecting the biologically active protein
and peptide-based drug compounds from the detrimental
eﬀects of biological ﬂuids. Newer nanoprodrug approaches
have also been applied, which has posed enhanced therapeu-
tic eﬃcacy along with superior circulation time.
Emerging methodologies for formulation of nanodrug
delivery systems include newer versions of the top-down
and bottom-up approaches. Additionally allied technologies
such as atomization and pressurization have come in to play2 Journal of Drug Delivery
to facilitate the preparation of nanotechnological carriers.
One such comprises a novel method of atomization, namely,
electrohydrodynamic atomization used in electrospraying
method. Pressurization techniques such as high hydrostatic
pressuretechnologyforencapsulationofgenesintopolymer-
ic nanomaterials have recently been studied for their eﬃcacy
in delivering the biologically active compounds. These novel
technologies oﬀer advantages by eliminating the usage of
toxic cationic polymers and chemical tethers further replac-
ing them simple yet eﬀective hydrogen bonding. Such ad-
vantagesandsimpliﬁcationsoftheprocesshavealreadygiven
their imminent revolutions in the ﬁeld of drug delivery.
With these advancements in the novel nanocarriers and
their applicability, the analytical tools are also not lagging
behind. In order to cope up with this and stand aside, newer
evaluation methodologies are already in move of their devel-
opment. These include scanning probe microscopy, more
speciﬁcally atomic force microscopy and scanning tunneling
microscopy, which have great capabilities for molecular and
submolecular characterizations.
Furthermore, various platform technologies at the nano-
scale, often referred as nanoplatforms, have been coming
in to play and booming for widespread applications of
these cutting edge technologies for its applicability at end
users. Basically, the common ones in the race include the
nanocrystals (nanopure, nanoedge, Dissocubes), nanoma-
terials (fullerenes, carbon nanotubes, and nanoparticles),
nanomedicines, molecular self-assemblies (self-assembled
monolayers, supramolecular assemblies and DNA nanotech-
nologies), nanoelectronics (in silico technologies), and so on
to name a few. The extension and appliance will be the state-
of-art for future research.
Finally, the common undeniable opinion highlighted in
this issue is that, although it is too early to say whether
these nanocarriers will wean the world from its current
limitations, or monumentally backﬁre to cause harm, a deep
understanding of the various mechanisms underneath the
reported ﬁndings will favor great discoveries, even at the
nanoscale.
In nutshell, eﬀorts are extensively made for utilizing the
nanotechnology concepts for advancements in the current
drug delivery sciences and, further to this, the fruitfulness of
the eﬀorts has been achieved which is well reﬂected in this
present issue.
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